Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine to prevent oxaliplatin-induced acute neuropathic pain
NL-OMON42676Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chemotherapy-induced peripheral neuropathy (CIPN) and colorectal cancer (CRC) comparing Lidocaine + oxaliplatin with Placebo + oxaliplatin (2 arms). Started Jun 2017; status: recruiting.
02
Drugs
lidocaine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)colorectal cancer (CRC)
Beyond the preview
Go deeper on NL-OMON42676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42676.